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Loss-of-Function Mutations in the WNT Co-receptor
LRP6 Cause Autosomal-Dominant Oligodontia
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Marco S. Cune,4,5 Sanne M.C. Savelberg,1 Isaa¨c J. Nijman,1 Madelon M. Maurice,3
Marie-Jose´ H. van den Boogaard,1,7 and Gijs van Haaften1,7,*
Tooth agenesis is one of the most common developmental anomalies in man. Oligodontia, a severe form of tooth agenesis, occurs both
as an isolated anomaly and as a syndromal feature. We performed exome sequencing on 20 unrelated individuals with apparent non-
syndromic oligodontia and failed to detect mutations in genes previously associated with oligodontia. In three of the probands, we de-
tected heterozygous variants in LRP6, and sequencing of additional oligodontia-affected individuals yielded one additional mutation in
LRP6. Threemutations (c.1144_1145dupAG [p.Ala383Glyfs*8], c.1779dupT [p.Glu594*], and c.2224_2225dupTT [p.Leu742Phefs*7]) are
predicted to truncate the protein, whereas the fourth (c.56C>T [p.Ala19Val]) is a missense variant of a conserved residue located at the
cleavage site of the protein’s signal peptide. All four affected individuals harboring a LRP6mutation had a family history of tooth agen-
esis. LRP6 encodes a transmembrane cell-surface protein that functions as a co-receptor withmembers from the Frizzled protein family in
the canonical Wnt/b-catenin signaling cascade. In this same pathway, WNT10A was recently identified as a major contributor in the
etiology of non-syndromic oligodontia.We show that the LRP6missense variant (c.56C>T) results in altered glycosylation and improper
subcellular localization of the protein, resulting in abrogated activation of the Wnt pathway. Our results identify LRP6 variants as
contributing to the etiology of non-syndromic autosomal-dominant oligodontia and suggest that this gene is a candidate for screening
in DNA diagnostics.Agenesis of one or more permanent teeth is a common
developmental anomaly with a prevalence of 5.5% in
Europe. Common forms affecting one or a few teeth repre-
sent the great majority of cases. More severe phenotypes
become increasingly more rare and are observed in approx-
imately 0.14% of the population.1,2 Oligodontia (ICD-10:
K00.0), defined as the absence of six or more permanent
teeth excluding the third molars, can occur either as an
isolated trait (non-syndromic) or as a part of a recognized
clinical syndrome and has a heterogeneous dental and
dental-facial presentation.3,4
Both environmental and genetic factors, as indicated by
familial occurrence, play a role in the etiology of tooth
agenesis.5 Inheritance can follow autosomal-dominant,
recessive, or sex-linked patterns, and mutations in a num-
ber of genes have been associated with non-syndromic
oligodontia. The genes currently associated with non-
syndromic oligodontia areMSX1 (muscle segment homeo-
box 1 [MIM: 142983]),6 PAX9 (paired box gene 9 [MIM:
167416]),7 AXIN2 (axis inhibition protein 2 [MIM:
604025]),8 and the ectodermal dysplasia genes EDA (ecto-
dysplasin A [MIM: 300451]), EDAR (ectodysplasin A re-
ceptor [MIM: 604095]), and EDARADD (edar-associated
death domain [MIM: 606603]).9–12 Recently, mutations
in WNT10A (wingless-type MMTV integration site family,
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The Americof 34 unrelated individuals with nonsyndromic oligodon-
tia.13 The objective of the present study was to identify dis-
ease-causing variants in genes not known to be involved in
the etiology of tooth agenesis by means of whole-exome
sequencing (WES) analysis of a cohort of non-syndromic
oligodontia cases.
Individuals with apparent isolated oligodontia and
visiting the Departments of Oral andMaxillofacial Surgery,
Prosthodontics, and Special Dental Care of the University
Medical Center Utrecht (UMC Utrecht) and the Antonius
Hospital Nieuwegein were referred to the Department of
Medical Genetics of UMC Utrecht for syndrome diagnos-
tics and genetic counseling. Tooth agenesis in the affected
individuals was assessed by clinical examination by the
dentist and on panoramic radiographs. After careful phys-
ical examination by a single clinical geneticist, 20 individ-
uals (6 males and 14 females) with six or more missing per-
manent teeth, excluding the third molars, were classified
as displaying non-syndromic oligodontia without ecto-
dermal features. No specific syndrome diagnose could be
identified and confirmed. Blood samples were obtained,
and after exclusion of mutations in the genes WNT10A,
MSX1, PAX9, IRF6, EDA, and AXIN2, WES analysis was per-
formed. Informed consent for WES as a part of the diag-
nostic process (approved by the medical ethical committee
of UMC Utrecht) was obtained for all subjects included inMedical Centre Utrecht, 3508 AB Utrecht, the Netherlands; 2Department
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this study. Informed consent for Sanger sequencing anal-
ysis was obtained for all subjects included in this study.
For WES, we prepared DNA libraries of the affected indi-
viduals by using Kapa Biosystems reagents and enriched
these with Agilent SureSelect All Exon V5 and a custom
pooling protocol. In brief, with a Covaris S2 sonicator,
we sheared 1 ug of purified gDNA (QIAGEN) into 100–
500 bp fragments that we then blunt ended, 50 phosphor-
ylated, and A-tailed by using KapaBiosystems reagents.
Next, we ligated adaptors containing the Illumina barcode
sequences to each sample and amplified for seven PCR cy-
cles. Finally, we quantified and equimolarly pooled three
samples into one library batch. Barcode blockers for the
Illumina adaptor sequences and barcodes were added,
and we enriched the library according to the Agilent Sure-
Select V5 exome protocol and finally PCR amplified the
library for ten cycles. Two enriched libraries were then
pooled and sequenced on a full-flow cell as a rapid run
on the Illumina HiSeq 2500 with 100-bp paired-end reads
at the Utrecht Sequencing Facility in the Netherlands.
We performed sequence alignment and variant calling
against the reference human genome (UCSC Human
Genome Browser hg19) by using the Burrows-Wheeler
Aligner (BWA),14 and we processed the data with the
Genome Analysis Toolkit (GATK) v.3.1.1,15 according to
best practice guidelines.16,17 Mean target coverage was be-
tween 66.23 and 110.23 with 94.2%–95.6% of the targets
being covered at greater than or equal to 103.
A multi-sample.vcf file was created and imported into
several analysis tools for annotation and interpretation.
Cartagenia Bench Lab NGS was used for variant interpreta-
tion, as well as Combined Annotation Dependent Deple-
tion (CADD) for variant prioritization. We analyzed the
data first with a dominant inheritance model, followed
by a recessive model. We prioritized variants on the basis
of the population frequency, their presence in clinical
variant databases such as the Human Gene Mutation Data-
base (HGMD), and predicted effects at the protein level.
Candidate variants were visualized in the integrated geno-
mics viewer (IGV),18 and were validated with Sanger
sequencing, followed by segregation analysis in relevant
family members. Primer information is available upon
request.
For the dominant inheritance model, we excluded vari-
ants with a minor allele frequency (MAF) > 1% as seen
in the 1000 Genomes Project, NHLBI GO Exome
Sequencing Project (ESP, 6500 release), or the Genome of
the Netherlands19 variant-frequency databases. Next, we
determined putative pathogenic frameshift, stop-loss,
stop-gain, start-loss, splice-site, and nonsynonymous
variants. Initially, we included nonsynonymous variants
on the basis of a majority rule of three functional-effect
prediction tools: SIFT (< 0), FATHMM (< 0), and Muta-
tionTaster (disease causing). We used the remaining
2,704 variants to rank genes based on recurrence in
different individuals. In 349 genes, we found two or
more variants. After gene prioritization and relevant litera-622 The American Journal of Human Genetics 97, 621–626, Octoberture inspection, we deemed LRP6 (low-density lipoprotein
receptor-related protein 6 [MIM: 603507]) the most likely
candidate gene to be involved in tooth agenesis. Subse-
quently, eight additional subjects without causative muta-
tions in oligodontia-associated genes were analyzed by
Sanger sequencing. This yielded one additional mutation
in LRP6.
In total, we found four heterozygous variants in LRP6
(GenBank: NM_002336.2) in four unrelated individuals.
These variants include a nonsense mutation (c.1779dupT
[p.Glu594*]) and two two-nucleotide insertion muta-
tions (c.2224_2225dupTT [p.Leu742Phefs*7], c.1144_
1145dupAG [p.Ala383Glyfs*8]) resulting in a truncated
mRNA product as well as a missense variant (c.56C>T
[p.Ala19Val]) located at the cleavage site of the signal pep-
tide of the protein. All four variants are absent in all
relevant variation databases, including the Single Nucleo-
tide Polymorphism Database (dbSNP), 1000 Genomes,
the NHLBI Exome Project, and the Exome Aggregation
Consortium (ExAC; accessed May, 2015). The (c.56C>T)
missense variant is rated deleterious by several in-silico-
prediction software programs (SIFT score ¼ 0.04; FATHMM
score ¼ 3.2; MutationTaster ¼ disease causing; CADD_
phred ¼ 19.3).
Sanger sequencing confirmed that all four individuals
were heterozygous for the mutations. Segregation analysis
showed that all had a family history of tooth agenesis. We
observed incomplete penetrance for the oligodontia
phenotype with the LRP6 variant seen in index-case indi-
vidual F4-II-1 (Figure 1A). The probands were characterized
by a high number of agenetic teeth, whereas the number of
missing teeth in the affected family members varied.
Furthermore, we found taurodontism in one third of
affected individuals (Figure S1). Taurodontism is also asso-
ciated with WNT10A mutations.20 Dental characteristics
for the probands and their family members are described
in Table S1. As mentioned, no specific syndrome diagnosis
could be confirmed in the probands. However, upon
further investigation, all affected members of family F3
showed minor anatomical variation of the ear and under-
development of the thumb (Figure S2). Lacrimal glands
and ducts showed no abnormalities.
LRP6 encodes a transmembrane cell-surface protein that,
together with members of the seven-pass transmembrane
receptors of the Frizzled family, functions as a co-receptor
in the canonical Wnt/b-catenin signaling cascade. LRP6
contains a large extracellular domain (ECD) to which
Wnt-proteins are known to bind. It has amodular structure
of four b-propeller domains interconnected by an EGF-like
domain followed by three LDLR type A ligand-binding do-
mains.21 Figure 1B shows a schematic representation of the
various protein domains and the location of the three mu-
tations identified in this study.
Both the nonsense mutation (c.1779dupT) and
the insertion mutations (c.2224_2225dupTT, c.1144_
1145dupAG) result in a premature stop codon in the mid-
dle of the putative protein product, and the resulting1, 2015
CB
A Figure 1. Dominant LRP6 Loss-of-Func-
tion Mutations Co-segregate with the Oli-
godontia Phenotype
(A) Black squares and circles representmale
and female individuals affected by oligo-
dontia, respectively. An arrow indicates
the index individual in each family.
Numbers in italics indicate the number of
missing teeth for that particular family
member. T indicates that taurodontia is
observed. Colors indicate presence (red)
or absence (green) of the LRP6 variant as
found in the index case. All affected family
members carry LRP6 variants. No variants
have been found in tested unaffected fam-
ily members.
(B) Representation of LRP6 with the de-
picted domains. Black arrows indicate
the locations of variants found in this
study. The missense variant (p.Ala19Val)
is found at the penultimate position of
the signal peptide domain. The predicted
protein truncating variants (p.Glu594*
and p.Leu742Phefs*7) are located in the
third EGF-like and b-propeller domains,
respectively.
(C) SignalP predictions for the WT and
p.Ala19Val LRP6 signal peptide sequences.
The S score is a general signal peptide score
and this score is mostly unaltered between
the p.Ala19Val and WT LRP6 signal pep-
tide sequences. However, the C-score (raw
cleavage-site score) and Y-score (combined
cleavage-site score) predict a complete loss
of a signal peptide cleavage site after amino
acid 20 in the altered amino acid sequence.transcripts are predicted to undergo nonsense-mediated
mRNA decay. The missense variant (c.56C>T) is found at
the penultimate amino acid position of the signal peptide
sequence. Interestingly, the SignalP 4.1 server predicts the
altered amino acid sequence for this variant to have lost its
signal peptide cleavage site, (Figure 1C).22
To gain insights into the molecular mechanism by which
the p.Ala19Val substitution in LRP6 affects its biological ac-
tivity, we compared the protein amounts of mouse wild-
type (WT) Lrp6 (Lrp6-GFP) and the variant counterpart,
generated by site-directed mutagenesis (Lrp6 p.Ala19Val-
GFP). HEK293T cells grown in 24-well plates were trans-
fected with increasing amounts of Lrp6-GFP or Lrp6
p.Ala19Val-GFP (1.25 ng, 2 ng, 5 ng, and 10 ng), lysed afterThe American Journal of Human G24 hr, and analyzed by immunoblot-
ting with mouse anti-GFP (Roche)
and mouse anti-actin (C4; MP Bio-
medicals). Whereas WT Lrp6-GFP
was processed to the fully glycosylated
mature form, Lrp6 p.Ala19Val-GFP
only displayed a single protein band
of lower molecular weight (MW),
most likely representing the immature
high-mannose precursor that is gener-
ated in the endoplasmic reticulum(ER) during the early steps of biogenesis (Figure 2A).
Furthermore, the protein amount of Lrp6 p.Ala19Val-GFP
was reproducibly lower as compared to that of WT Lrp6,
suggesting impaired biogenesis of the altered protein or
enhanced turnover.
To confirm that Lrp6 p.Ala19Val is retained in the ER in
its immature high-mannose form, we determined the
sensitivity of the altered protein to Endoglycosidase H (En-
doH) activity. EndoH cleaves high-mannose glycans that
are added to nascent proteins in the ER. When proteins
enter the Golgi, additional glycan modifications occur,
rendering the resulting complex glycan chains resistant
to EndoH digestion. In brief, HEK293T cells grown in six-
well plates were transfected with 200 ng of Lrp6-GFP orenetics 97, 621–626, October 1, 2015 623
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Figure 2. The Defective Signaling Capac-
ity of Lrp6 p.Ala19Val Is Due to ER Reten-
tion of the Altered Protein
(A) Lrp6 p.Ala19Val fails to acquire Golgi-
dependent complex glycosylation. Immu-
noblot analysis of increasing amounts of
WT Lrp6-GFP and Lrp6 p.Ala19Val-GFP
transfected in HEK293T cells is shown.
Actin loading controls are shown. The
immature and fully glycosylated mature
forms of Lrp6 are indicated by a white
and a black arrowhead, respectively.
(B) Lrp6 p.Ala19Val is trapped in the ER.
HEK293T cells were transfected with WT
Lrp6-GFP or Lrp6 p.Ala19Val-GFP and cell
lysates were treated with the indicated gly-
cosidases. Gray, white, and black arrow-
heads indicate deglycosylated, immature
ER-resident (high-mannose), and mature
complex glycosylated Lrp6-GFP forms,
respectively.
(C) Lrp6 p.Ala19Val fails to reach the cell
surface. Cellular localization of WT and
altered Lrp6-GFP transfected in HEK293T
cells in the presence or absence of Brefeldin
A (BFA) treatment, as analyzed by confocal
immunofluorescence microscopy. The ER
was stained with anti-KDEL antibody.
Graphs indicate relative intensity of GFP
fluorescence across the yellow line.
(D and E) The capacity of Lrp6 p.Ala19Val
to induce Wnt signaling is severely
compromised. Wnt pathway activation in-
duced by increasing amounts of Lrp6-
GFP and Lrp6 p.Ala19Val-GFP was mea-
sured with a luciferase gene reporter
assay in HEK293T cells. Activities were
compared in the absence and presence of
Wnt3a and co-transfection of Frizzled-5
(Fzd5), as indicated. Empty vector-trans-
fected cells (C-) serve as an internal con-
trol. Results represent duplicate experi-
ments. Luciferase activity was normalized
against unstimulated controls; error bars
depict SDs.Lrp6 p.Ala19Val-GFP and lysed after 24 hr. Cell lysates were
incubated with either EndoH (Roche) or Peptide-N-Glyco-
sidase F (PNGase F; New England Biolabs) for 5 hr at 37C
and analyzed by immunoblotting. As shown in Figure 2B,
the low MW protein bands of both WT and altered Lrp6624 The American Journal of Human Genetics 97, 621–626, October 1, 2015were sensitive to EndoH treatment,
as suggested by a shift to a lower
MW deglycosylated form, whereas
the complex glycosylated mature
form of WT Lrp6 remained unaf-
fected. As expected, both protein
bands were sensitive to PNGase F,
which hydrolyses all N-linked gly-
cans. These results argue that the
p.Ala19Val variant causes retention
of the nascent Lrp6 in the ER, poten-
tially due to a failure in the cleavage
of the signal peptide.To substantiate these findings, we investigated by
confocal microscopy whether Lrp6 p.Ala19Val could be
transported to the plasma membrane. To this end,
HEK293T cells grown on laminin-coated glass coverslips
in 24-well plates were transfected with 100 ng of either
Lrp6-GFP or Lrp6 p.Ala19Val-GFP. The next day, cells were
fixed in 4% paraformaldehyde or incubated with 10 mg/ml
Brefeldin A (BFA) for 5 hr before fixation. Anti-KDEL anti-
body (Abcam) was used as an ER marker. Whereas the
WT protein is mainly present at the cell surface, Lrp6
p.Ala19Val colocalizes with KDEL and does not reach the
plasma membrane (Figure 2C). Importantly, upon treat-
ment with the ER-Golgi trafficking inhibitor BFA, WT
Lrp6 displayed a similar perinuclear ER-like localization,
whereas no major differences were detected for Lrp6
p.Ala19Val, suggesting that the mutation phenocopies
the BFA effect.
Given that Lrp6 is a major component of the Wnt recep-
tor complex in the canonical Wnt pathway, we sought to
investigate the signaling capacity of the altered protein
by using the previously described TOPFlash luciferase
reporter assay, which provides a highly specific and quan-
titative readout for Wnt pathway activity.23 Increasing
amounts of WT Lrp6-GFP in HEK293T cells induced a
dose-dependent activation of b-catenin-mediated tran-
scription (Figure 2D). Strikingly, under the same condi-
tions, altered Lrp6 p.Ala19Val-GFP failed to trigger b-cate-
nin activation, indicating its inability to activate the Wnt
pathway. In Wnt stimulated cells, the Lrp6 receptor relays
the Wnt signal together with the seven span Frizzled (Fzd)
receptor, forming a trimeric complex (Wnt-Fzd-Lrp6) at
the cell surface.24 We next addressed the signaling capacity
of the Lrp6 p.Ala19Val variant in the presence of high
Fzd5 amounts. To this end, cells were co-transfected with
increasing amounts of either WT or altered Lrp6 along
with 30 ng Fzd5.25 Similar to the results above, Lrp6
p.Ala19Val-GFP was not able to enhance Wnt signaling
induced by Fzd5 expression, irrespective of the amount
of transfected altered Lrp6 DNA (Figure 2D). By compari-
son, combined expression of both WT Lrp6 and Fzd5
strongly enhanced reporter activity. Moreover, Lrp6
p.Ala19Val-GFP expressing cells failed to induce enhanced
Wnt pathway activation upon stimulation for 16 hr with
exogenous Wnt3a-conditioned medium derived from sta-
bly transfected murine L cells (Figure 2E). Together, these
findings show that the Lrp6 p.Ala19Val variant confers
loss-of-function effects upon the Lrp6 receptor as a result
of ER retention, thereby rendering the protein invisible
for incoming Wnt ligands at the cell surface.
Missense variants in LRP6 have been associated with cor-
onary artery disease (CAD)26,27 andmetabolic syndrome;28
however, these phenotypes were not observed in our
affected individuals. In contrast, no nonsense, frameshift,
or splice-site variants have been reported thus far. Most
likely, the loss-of-function variants reported here represent
a different functional class of mutations.
Mouse embryos homozygous for an Lrp6 insertion mu-
tation have been shown to die at birth and exhibit a variety
of severe developmental abnormalities that are a striking
composite of developmental abnormalities caused by mu-
tations in individual Wnt genes. Also, the phenotype of a
classical Wnt-3a hypomorphic allele, vestigial tail (vt), isThe Americenhanced upon elimination of one functional copy of
Lrp6. This observation is believed to provide genetic evi-
dence that Lrp6 and Wnt-3a function in the same
pathway.29 Subsequently, it has been shown that 10% of
mice heterozygous for this Lrp6 insertion mutation show
a tail-kink phenotype, indicating that haploinsufficiency
of Lrp6 is sufficient to generate a phenotype in the
mouse.30 However, tooth anomalies have not been re-
ported in these animals.
In this study, we identified four heterozygous LRP6
loss-of-function mutations in four independent families
affected by severe tooth agenesis. Segregation in these fam-
ilies follows an autosomal-dominant inheritance pattern
with reduced penetrance and variable expression; this
observation is in accordance with familial segregation
and twin studies.2 Given that LRP6 is a key co-receptor
in the canonical Wnt/b-catenin pathway, our results
strengthen the notion that disruption of important devel-
opmental pathways such as the Wnt-pathway is of impor-
tance in the etiology of tooth agenesis.
In conclusion, we here provide genetic and functional
evidence that mutations in LRP6 are a cause of non-syn-
dromic tooth agenesis, and our results suggest that this
gene is a candidate for screening in DNA diagnostics.Supplemental Data
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